Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.

An independent watchdog finds the IRS has improved its overall taxpayer service but is slow to resolve certain identity theft ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

The Massachusetts Municipal Wholesale Electric Co. received $2.3 million from a clean energy tax credit program included in ...

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

Former North Dakota governor Doug Burgum, an outspoken proponent of carbon capture, committed to making his state carbon ...

It will be up to Parliamentarian Elizabeth MacDonough to determine whether the provisions in their reconciliation bills can ...

The Biden administration has achieved a fourth consecutive record year in HealthCare.gov Marketplace enrollment, one week ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Democrats in the House and Senate reintroduced legislation Thursday to permanently extend enhanced subsidies to help people ...